Cargando…
Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents
Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma (MM). PCL is characterized by peripheral blood involvement by malignant plasma cells and an aggressive clinical course leading to poor survival. There is considerable overlap between MM and PCL with respect to cl...
Autores principales: | Chaulagain, Chakra P, Diacovo, Maria-Julia, Van, Amy, Martinez, Felipe, Fu, Chieh-Lin, Jimenez Jimenez, Antonio Martin, Ahmed, Wesam, Anwer, Faiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917418/ https://www.ncbi.nlm.nih.gov/pubmed/33716516 http://dx.doi.org/10.1177/2634853521999389 |
Ejemplares similares
-
Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients
por: Chaulagain, Chakra P., et al.
Publicado: (2020) -
Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature
por: Zerdan, Maroun Bou, et al.
Publicado: (2021) -
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia)
por: Bou Zerdan, Maroun, et al.
Publicado: (2022) -
Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma
por: Chaulagain, Chakra P, et al.
Publicado: (2022) -
Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice
por: Dima, Danai, et al.
Publicado: (2023)